• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于孕早期筛查中唐氏综合征风险预测的混合人工智能方法。

A Hybrid Artificial Intelligence Approach for Down Syndrome Risk Prediction in First Trimester Screening.

作者信息

Yalçın Emre, Aslan Serpil, Toğaçar Mesut, Demir Süleyman Cansun

机构信息

Department of Obstetrics and Gynecology, Division of Perinatology, Cukurova University School of Medicine, 01330 Adana, Turkey.

Department of Computer Engineering, Faculty of Engineering and Natural Sciences, Malatya Turgut Ozal University, 44210 Malatya, Turkey.

出版信息

Diagnostics (Basel). 2025 Jun 6;15(12):1444. doi: 10.3390/diagnostics15121444.

DOI:10.3390/diagnostics15121444
PMID:40564765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192227/
Abstract

The aim of this study is to develop a hybrid artificial intelligence (AI) approach to improve the accuracy, efficiency, and reliability of Down Syndrome (DS) risk prediction during first trimester prenatal screening. The proposed method transforms one-dimensional (1D) patient data-including features such as nuchal translucency (NT), human chorionic gonadotropin (hCG), and pregnancy-associated plasma protein A (PAPP-A)-into two-dimensional (2D) Aztec barcode images, enabling advanced feature extraction using transformer-based deep learning models. : The dataset consists of 958 anonymous patient records. Each record includes four first trimester screening markers, hCG, PAPP-A, and NT, expressed as multiples of the median. The DS risk outcome was categorized into three classes: high, medium, and low. Three transformer architectures-DeiT3, MaxViT, and Swin-are employed to extract high-level features from the generated barcodes. The extracted features are combined into a unified set, and dimensionality reduction is performed using two feature selection techniques: minimum Redundancy Maximum Relevance (mRMR) and RelieF. Intersecting features from both selectors are retained to form a compact and informative feature subset. The final features are classified using machine learning algorithms, including Bagged Trees and Naive Bayes. : The proposed approach achieved up to 100% classification accuracy using the Naive Bayes classifier with 1250 features selected by RelieF and 527 intersecting features from mRMR. By selecting a smaller but more informative subset of features, the system significantly reduced hardware and processing demands while maintaining strong predictive performance. : The results suggest that the proposed hybrid AI method offers a promising and resource-efficient solution for DS risk assessment in first trimester screening. However, further comparative studies are recommended to validate its performance in broader clinical contexts.

摘要

本研究的目的是开发一种混合人工智能(AI)方法,以提高孕早期产前筛查中唐氏综合征(DS)风险预测的准确性、效率和可靠性。所提出的方法将一维(1D)患者数据(包括颈项透明层(NT)、人绒毛膜促性腺激素(hCG)和妊娠相关血浆蛋白A(PAPP-A)等特征)转换为二维(2D)阿兹特克条形码图像,从而能够使用基于Transformer的深度学习模型进行高级特征提取。数据集由958份匿名患者记录组成。每份记录包括四个孕早期筛查标志物,即hCG、PAPP-A和NT,以中位数倍数表示。DS风险结果分为三类:高、中、低。采用三种Transformer架构——DeiT3、MaxViT和Swin——从生成的条形码中提取高级特征。将提取的特征合并成一个统一的集合,并使用两种特征选择技术进行降维:最小冗余最大相关性(mRMR)和RelieF。保留两个选择器的相交特征,以形成一个紧凑且信息丰富的特征子集。使用包括Bagged Trees和朴素贝叶斯在内的机器学习算法对最终特征进行分类。所提出的方法使用朴素贝叶斯分类器,在通过RelieF选择的1250个特征和来自mRMR的527个相交特征的情况下,实现了高达100%的分类准确率。通过选择一个更小但更具信息性的特征子集,该系统在保持强大预测性能的同时,显著降低了硬件和处理需求。结果表明,所提出的混合AI方法为孕早期筛查中的DS风险评估提供了一种有前景且资源高效的解决方案。然而,建议进行进一步的比较研究,以验证其在更广泛临床背景下的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/ef81f9610ec6/diagnostics-15-01444-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/c25f71901a8a/diagnostics-15-01444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/33c6a210ca4d/diagnostics-15-01444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/e7fd216dbab4/diagnostics-15-01444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/1a44e3abc9b5/diagnostics-15-01444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/e1b624e3609e/diagnostics-15-01444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/7e589b558e93/diagnostics-15-01444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/b013c1ecc6ff/diagnostics-15-01444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/d63a141ee270/diagnostics-15-01444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/4ac9393984d2/diagnostics-15-01444-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/eb88634bf279/diagnostics-15-01444-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/bcd5b48bc872/diagnostics-15-01444-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/d88285abcb57/diagnostics-15-01444-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/59a82ab7f933/diagnostics-15-01444-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/ef81f9610ec6/diagnostics-15-01444-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/c25f71901a8a/diagnostics-15-01444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/33c6a210ca4d/diagnostics-15-01444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/e7fd216dbab4/diagnostics-15-01444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/1a44e3abc9b5/diagnostics-15-01444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/e1b624e3609e/diagnostics-15-01444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/7e589b558e93/diagnostics-15-01444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/b013c1ecc6ff/diagnostics-15-01444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/d63a141ee270/diagnostics-15-01444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/4ac9393984d2/diagnostics-15-01444-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/eb88634bf279/diagnostics-15-01444-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/bcd5b48bc872/diagnostics-15-01444-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/d88285abcb57/diagnostics-15-01444-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/59a82ab7f933/diagnostics-15-01444-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a0a/12192227/ef81f9610ec6/diagnostics-15-01444-g014.jpg

相似文献

1
A Hybrid Artificial Intelligence Approach for Down Syndrome Risk Prediction in First Trimester Screening.一种用于孕早期筛查中唐氏综合征风险预测的混合人工智能方法。
Diagnostics (Basel). 2025 Jun 6;15(12):1444. doi: 10.3390/diagnostics15121444.
2
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.孕早期单独进行超声检查或与孕早期血清检查联合用于唐氏综合征筛查。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600.
3
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.深度学习方法在自身免疫性大疱性疾病中的直接免疫荧光模式识别。
Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142.
4
First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.用于唐氏综合征筛查的孕早期和孕中期血清检测,以及有无孕早期超声检查的情况。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012599. doi: 10.1002/14651858.CD012599.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
7
Skin-CAD: Explainable deep learning classification of skin cancer from dermoscopic images by feature selection of dual high-level CNNs features and transfer learning.皮肤 CAD:基于双高级 CNN 特征选择和迁移学习的皮肤镜图像皮肤癌可解释深度学习分类。
Comput Biol Med. 2024 Aug;178:108798. doi: 10.1016/j.compbiomed.2024.108798. Epub 2024 Jun 25.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
An overview and evaluation of first-trimester physiological fetal human anatomy using 3-dimensional ultrasound combined with virtual reality techniques.使用三维超声结合虚拟现实技术对孕早期生理性胎儿人体解剖结构的概述与评估。
Hum Reprod. 2025 Jun 27. doi: 10.1093/humrep/deaf112.
10
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.

引用本文的文献

1
Multiplexed Quantification of First-Trimester Serum Biomarkers in Healthy Pregnancy.健康妊娠早期血清生物标志物的多重定量分析
Int J Mol Sci. 2025 Aug 18;26(16):7970. doi: 10.3390/ijms26167970.

本文引用的文献

1
Prediction of high-risk pregnancy based on machine learning algorithms.基于机器学习算法的高危妊娠预测
Sci Rep. 2025 May 4;15(1):15561. doi: 10.1038/s41598-025-00450-3.
2
Research advancements in the Use of artificial intelligence for prenatal diagnosis of neural tube defects.人工智能在神经管缺陷产前诊断中的应用研究进展
Front Pediatr. 2025 Apr 17;13:1514447. doi: 10.3389/fped.2025.1514447. eCollection 2025.
3
Machine Learning-Based Prediction of First Trimester Down Syndrome Risk in East Asian Populations.基于机器学习的东亚人群孕早期唐氏综合征风险预测
Risk Manag Healthc Policy. 2025 Mar 29;18:1109-1120. doi: 10.2147/RMHP.S511035. eCollection 2025.
4
Detection of Thymoma Disease Using mRMR Feature Selection and Transformer Models.基于最小冗余最大相关(mRMR)特征选择和Transformer模型的胸腺瘤疾病检测
Diagnostics (Basel). 2024 Sep 29;14(19):2169. doi: 10.3390/diagnostics14192169.
5
Genomic abnormalities in apparently isolated polyhydramnios and the role of confirmed fetal phenotype: a systematic review and meta-analysis.在明显孤立性羊水过多症中出现的基因组异常,以及确认的胎儿表型的作用:系统评价和荟萃分析。
Am J Obstet Gynecol MFM. 2024 Oct;6(10):101469. doi: 10.1016/j.ajogmf.2024.101469. Epub 2024 Aug 22.
6
Validation of the first-trimester machine learning model for predicting pre-eclampsia in an Asian population.验证用于预测亚洲人群先兆子痫的早期机器学习模型。
Int J Gynaecol Obstet. 2024 Oct;167(1):350-359. doi: 10.1002/ijgo.15563. Epub 2024 Apr 26.
7
Improving prediction of maternal health risks using PCA features and TreeNet model.使用主成分分析(PCA)特征和TreeNet模型改善对孕产妇健康风险的预测。
PeerJ Comput Sci. 2024 Apr 15;10:e1982. doi: 10.7717/peerj-cs.1982. eCollection 2024.
8
Attention is all you need: utilizing attention in AI-enabled drug discovery.注意力就是你需要的一切:在人工智能药物发现中利用注意力机制。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad467.
9
Deep hybrid model for maternal health risk classification in pregnancy: synergy of ANN and random forest.用于孕期孕产妇健康风险分类的深度混合模型:人工神经网络与随机森林的协同作用
Front Artif Intell. 2023 Jul 5;6:1213436. doi: 10.3389/frai.2023.1213436. eCollection 2023.
10
A Novel Framework for Abnormal Risk Classification over Fetal Nuchal Translucency Using Adaptive Stochastic Gradient Descent Algorithm.一种使用自适应随机梯度下降算法对胎儿颈部透明带异常风险进行分类的新框架。
Diagnostics (Basel). 2022 Oct 31;12(11):2643. doi: 10.3390/diagnostics12112643.